Digital Health Literacy on COVID-19 for All: Co-creation and Evaluation of Interventions for Ethnic Minorities and Chinese People With Chronic Illnesses in Hong Kong

Sponsor
The Hong Kong Polytechnic University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06004323
Collaborator
(none)
528
2
16

Study Details

Study Description

Brief Summary

During the pandemic, people are anxious for information, and electronic platform serves the purpose of having first-hand health information and spreading it to massive population within a short time. However, the source and credibility of the influx of online information are hard to be verified. Digital health literacy (DHL) is the capacity to access, understand, evaluate, and apply health information from electronic sources, which is an important attribute that everyone should possess. Recent studies from our group in Hong Kong have shown that, during the COVID-19 pandemic, DHL is an issue facing people of all ages, especially ethnic minorities (EMs), people with chronic illnesses (PWCI), and professional and lay caregivers (CGs). Considering that, the present research project aims to co-create DHL interventions with these three groups of people to meet their specific needs in DHL, in addition, to assess the efficacy of the DHL interventions on eHealth literacy, vaccine literacy, and actions taken for COVID-19 prevention. The present research is a 4-year project, involving three phases. Phase 1 involves focus group interviews and cognitive interviews with the three groups of people for developing interventions and evaluating the proposed interventions. Phase 2 involves individual interviews with the three groups of people for testing the feasibility and acceptability of the interventions. Phase 3 involves a 6-month longitudinal quantitative research, testing for the efficacy of the interventions in three dimensions: literacy, attitude, and behavior. Participants from the three groups will be invited to join virtual or face-to-face training, watch short videos on social media, participate in virtual bi-weekly group discussion, and fill in questionnaires for five times during the course of the study. This co-creation of new knowledge by stakeholders and researchers is expected to increase the uptake of the research outcomes and adoption of the DHL interventions.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Digital health literacy intervention
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
528 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
This is a single-blinded, randomized controlled trial that outcome assessors will be prevented from having knowledge of the interventions assigned to individual participant
Primary Purpose:
Prevention
Official Title:
Digital Health Literacy on COVID-19 for All: Co-creation and Evaluation of Interventions for Ethnic Minorities and Chinese People With Chronic Illnesses in Hong Kong
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Digital health literacy intervention

The interventions will be developed based on the Best Practices for Digital Health Literacy, WHO health literacy toolkits and the findings of the interviews. The content to be covered in the intervention will include news about vaccines; alerts about COVID-19 preventive measures; guidelines on social distancing, COVID-19 screening test arrangements, vaccination and compulsory quarantines; COVID-19-related law enforcement; and self-monitoring of COVID-19 symptoms

Behavioral: Digital health literacy intervention
Participants from the intervention group will be invited to join virtual or face-to-face training, watch short videos on social media, participate in virtual bi-weekly group discussion, and fill in questionnaires for five times during the course of the study

No Intervention: Control

No intervention will be provided to the control group

Outcome Measures

Primary Outcome Measures

  1. eHealth Literacy Efficacy [baseline, 8-week post intervention, 4-week post follow-up, 8-week follow up, and 12 week follow up]

    Measured by the eHealth Literacy scale (eHEAL), an 8-item self-reported efficacy scale scored on a 5-point Likert scale

Secondary Outcome Measures

  1. Digital Health Literacy [baseline, 8-week post intervention, 4-week post follow-up, 8-week follow up, and 12 week follow up]

    Measured by Digital Health Literacy Instrument

  2. Vaccine literacy [baseline, 8-week post intervention, 4-week post follow-up, 8-week follow up, and 12 week follow up]

    knowledge about and intention to receive the COVID-19 vaccine

  3. Knowledge, attitudes, and practices towards COVID-19 [baseline, 8-week post intervention, 4-week post follow-up, 8-week follow up, and 12 week follow up]

    Assess knowledge, attitudes, and practices towards COVID-19

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • ethnic minorities (EMs), people with chronic illnesses (PWCI), and caregivers (CGs)

  • able to use a computer, smartphone, or laptop to access the Internet at home

Exclusion Criteria:
  • diagnosis of an acute psychotic disease or life-limiting condition; having a visual, auditory, or fine motor disorder.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • The Hong Kong Polytechnic University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr Angela Leung, Professor, The Hong Kong Polytechnic University
ClinicalTrials.gov Identifier:
NCT06004323
Other Study ID Numbers:
  • HSEARS20210902004
First Posted:
Aug 22, 2023
Last Update Posted:
Aug 22, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr Angela Leung, Professor, The Hong Kong Polytechnic University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 22, 2023